Swedish Growth Companies With High Insider Ownership In June 2024

In This Article:

As of June 2024, the Swedish market reflects a cautious optimism amidst a complex global economic landscape marked by fluctuating inflation rates and policy adjustments in Europe. In this environment, growth companies with high insider ownership stand out as potentially resilient investments, as significant insider stakes often align leadership interests with shareholder value creation.

Top 10 Growth Companies With High Insider Ownership In Sweden

Name

Insider Ownership

Earnings Growth

CTT Systems (OM:CTT)

16.9%

21.6%

BioArctic (OM:BIOA B)

35.1%

50.5%

Sileon (OM:SILEON)

33.3%

109.3%

InCoax Networks (OM:INCOAX)

18%

104.9%

KebNi (OM:KEBNI B)

37.8%

90.4%

Calliditas Therapeutics (OM:CALTX)

11.6%

53%

edyoutec (NGM:EDYOU)

14.6%

63.1%

Egetis Therapeutics (OM:EGTX)

17.6%

98.2%

Yubico (OM:YUBICO)

37.5%

42.5%

SaveLend Group (OM:YIELD)

24.9%

103.4%

Click here to see the full list of 82 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

Here's a peek at a few of the choices from the screener.

Medicover

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Medicover AB (publ) operates in the healthcare and diagnostics sector, offering services primarily in Poland and Sweden, as well as internationally, with a market capitalization of SEK 29.91 billion.

Operations: Medicover's revenue is primarily derived from its Healthcare Services and Diagnostic Services segments, generating €1.26 billion and €585.20 million respectively.

Insider Ownership: 11.1%

Medicover, a Swedish growth company with high insider ownership, is trading at 50.8% below its estimated fair value, suggesting potential undervaluation. The company recently reported significant earnings growth of 1492.9% over the past year and expects substantial future growth with earnings forecasted to increase by 38.2% annually over the next three years. However, its revenue growth projection of 14.5% per year lags behind this earnings surge and is slower than the desired 20% annual benchmark for high-growth firms. Additionally, Medicover's interest payments are not well covered by earnings, indicating some financial strain despite robust profit increases and optimistic revenue guidance exceeding €2.2 billion for year-end 2025.

OM:MCOV B Earnings and Revenue Growth as at Jun 2024
OM:MCOV B Earnings and Revenue Growth as at Jun 2024

Pandox

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pandox AB is a Swedish hotel property company specializing in owning, operating, and leasing hotel properties, with a market capitalization of approximately SEK 34.86 billion.